Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
6:59 PM UTC, 04/24/25 | |||
---|---|---|---|---|
Last: $37.35 | Change: +0.90 | %Change: +2.45% | Volume: 152,363 |
10:58 AM EST, 01/07/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Tuesday morning, rising 0.34% to 1,316.18 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company BioNTech (BNTX) and energy major Equinor (EQNR), which rose 4.8% and 3.4% respectively. They were followed by telecommunications company Nokia (NOK) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 2.1% and 1.7% respectively.
The decliners from continental Europe were led by internet browser company Opera (OPRA) and accommodations booking provider trivago (TRVG), which lost 4.6% and 3.9% respectively. They were followed by biotech company Evaxion Biotech (EVAX) and semiconductor company Sequans Communications (SQNS), which dropped 3.8% and 3.6% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and TC Biopharm (TCBP), which advanced 4.9% and 3.8% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Bicycle Therapeutics (BCYC), which increased 3.6% and 2.2% respectively.
The decliners from the UK and Ireland were led by biotech company Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which fell 4.3% and 4.1% respectively. They were followed by communications company WPP (WPP) and biopharmaceutical company NuCana (NCNA), which were down 3.8% and 3.1% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.